Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;42(9):2486-2495.
doi: 10.1002/hed.26277. Epub 2020 May 19.

Head and neck paragangliomas: 30-year experience

Cristina Valero  1 , Ian Ganly  1 , Jatin P Shah  1   2
Affiliations

Head and neck paragangliomas: 30-year experience

Cristina Valero et al. Head Neck. 2020 Sep.

Abstract

Background: We aimed to review our experience and the changing trends in the management of head and neck paragangliomas (HNPG) over the last three decades.

Methods: We retrospectively reviewed 103 patients with HNPG treated at our center (1986-2017). We included patients treated with surgery, radiotherapy, and patients maintained under active surveillance.

Results: Of the surgically treated patients (n = 79), 20% (12/59) of the carotid body tumors (CBT) had a cranial nerve deficit as sequela compared to 95% (19/20) of the non-CBT. Radiotherapy controlled growth in all tumors treated with this modality (n = 10). Of the initially observed patients, 70% (14/20) remained stable and did not require additional treatment. Stratifying by decades, there was a progressive increase in patients initially attempted to be observed and a decrease in upfront surgery. No deaths attributable to the HNPG were encountered.

Conclusions: Surgery is an effective treatment for CBT. Nonsurgical treatment should be considered for non-CBT.

Keywords: carotid body tumor; cranial nerve neoplasms; glomus tumor; head and neck neoplasms; paragangliomas.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflicts of interest pertinent to this work.

Figures

Figure 1.
Figure 1.
Flow diagram and description of the subtypes of paragangliomas included in the study.
See this image and copyright information in PMC

References

    1. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002;39:617–622. - PMC - PubMed
    1. McCaffrey TV, Myssiorek D, Marrinan M. Head and neck paragangliomas. Otolaryngol Clin North Am 2005;34:837–844. - PubMed
    1. Galan SR, Kann PH. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma. Clin Endocrinol (Oxf) 2013;78:165–175. - PubMed
    1. Fishbein L, Nathanson KL. Pheochromocytoma and paraganglioma: Understanding the complexities of the genetic background. Cancer Genet 2012;205:1–11. - PMC - PubMed
    1. Kruger AJ, Walker PJ, Foster WJ, Jenkins JS, Boyne NS, Jenkins J. Important observations made managing carotid body tumors during a 25-year experience. J Vasc Surg 2010;52:1518–1523. - PubMed

Publication types